American Conference Institute (ACI) will be holding its Hatch-Waxman and BPCIA Virtual Proficiency Series, a 3-week primer on IP basics and regulatory fundamentals on small molecule and biologic drugs and their generic and biosimilar equivalents, from October 5-21, 2021. In Week One, meeting on October 5th and 7th, the regulatory framework will be discussed, including: • The interplay between the PTO and FDA • Pre-commercialization concerns • Links between the FDA approval process and the patent process • The Orange Book Week Two, meeting on October 12th and 14th, will cover the Hatch-Waxman and BPCIA framework, including: • The Hatch-Waxman…
View the original article here: ACI Hatch-Waxman and BPCIA Virtual Proficiency Series
The article was originally posted on Patent Docs.
Each article is copyrighted to their original authors. We do not own any rights to the news or the images used. Whilst every care is taken to ensure that the news posts published are accurate, we cannot guarantee the authenticity of the news article on every occasion. There’s no copyright infringement intended. The news is for informational purposes only and does not provide legal advice.